| Net Cash Provided by (Used in) Operating Activities |
$17,800 |
USD |
-8.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$17,800 |
USD |
8.2% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
27,819,385 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$179,136 |
USD |
9.4% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$179,136 |
USD |
9.4% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$853,030 |
USD |
9.4% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$36,269 |
USD |
-0.27% |
Q3 2025 |
Q3 2025 |